Search Results - "Dees EC"

The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients.

Authors: Walko CM Combest AJ Spasojevic I et al.

Source: Cancer Chemotherapy & Pharmacology. May2012, Vol. 69 Issue 5, p1189-1196. 8p.

CLO26-104: TBCRC 050: A Phase 1b/2 Trial of Niraparib and Trastuzumab in HER2+ Metastatic Breast Cancer (MBC): Safety and Efficacy.

Authors: Stringer-Reasor E Li Y Zhang J et al.

Source: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2026 Mar 31; Vol. 24 (3.5). Date of Electronic Publication: 2026 Mar 31.

Publication Type: Journal Article

Journal Info: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Electronic Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE; In Process

Investigating initial patterns of progression on first-line treatment in patients with de novo metastatic breast cancer.

Authors: Huber E Gupta GP Morse R et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2026 Feb 21; Vol. 216 (2). Date of Electronic Publication: 2026 Feb 21.

Publication Type: Journal Article; Review

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b study.

Authors: Tolaney SM Jhaveri K Helsten T et al.

Source: Frontiers in oncology [Front Oncol] 2025 Mar 12; Vol. 15, pp. 1555921. Date of Electronic Publication: 2025 Mar 12 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

A Phase I Trial of Alpelisib Combined With Capecitabine in Patients With HER2-Negative Metastatic Breast Cancer.

Authors: File DM Abdou Y Force J et al.

Source: Clinical breast cancer [Clin Breast Cancer] 2024 Dec; Vol. 24 (8), pp. 683-690. Date of Electronic Publication: 2024 Aug 08.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE

Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938).

Authors: Villaruz LC Jin J Wang H et al.

Source: Cancer [Cancer] 2025 Nov 01; Vol. 131 (21), pp. e70157.

Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Phase 1/2 study of H3B-6545 in women with locally advanced/metastatic estrogen receptor-positive, HER2-negative breast cancer.

Authors: Hamilton E Pluard T Wang JS et al.

Source: Breast cancer research : BCR [Breast Cancer Res] 2025 Aug 19; Vol. 27 (1), pp. 151. Date of Electronic Publication: 2025 Aug 19.

Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study; Clinical Trial, Phase I

Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE

Overall survival in patients with hormone receptor-positive, HER2-negative advanced breast cancer treated in a phase 1b trial evaluating gedatolisib in combination with palbociclib and endocrine therapy.

Authors: Layman RM Han HS Rugo HS et al.

Source: The Lancet. Oncology [Lancet Oncol] 2025 Jul; Vol. 26 (7), pp. e332-e333.

Publication Type: Letter

Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE; In Process

CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial.

Authors: Reiss KA Angelos MG Dees EC et al.

Source: Nature medicine [Nat Med] 2025 Apr; Vol. 31 (4), pp. 1171-1182. Date of Electronic Publication: 2025 Feb 07.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Quality of Life Outcomes in Breast Cancer Patients Receiving Chemotherapy With or Without Radiation Therapy.

Authors: Morse RT Bean NW Hall J et al.

Source: Clinical breast cancer [Clin Breast Cancer] 2025 Jan; Vol. 25 (1), pp. e86-e93. Date of Electronic Publication: 2024 Aug 30.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE

Body mass index and patient-reported function, quality of life and treatment toxicity in women receiving adjuvant chemotherapy for breast cancer.

Authors: Nyrop KA Monaco J Vohra S et al.

Source: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2023 Mar 02; Vol. 31 (3), pp. 196. Date of Electronic Publication: 2023 Mar 02.

Publication Type: Journal Article

Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013.

Authors: Ademuyiwa FO Gao F Street CR et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2022 Dec 30; Vol. 8 (1), pp. 134. Date of Electronic Publication: 2022 Dec 30.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.

Authors: Grivas P Garralda E Meric-Bernstam F et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 15; Vol. 30 (20), pp. 4572-4583.

Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b Study.

Authors: Tolaney SM Beeram M Beck JT et al.

Source: Frontiers in oncology [Front Oncol] 2022 Feb 10; Vol. 11, pp. 810023. Date of Electronic Publication: 2022 Feb 10 (Print Publication: 2021).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer.

Authors: Nyrop KA Damone EM Deal AM et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Jan; Vol. 191 (2), pp. 409-422. Date of Electronic Publication: 2021 Nov 05.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Clinical and Genomic Risk for Late Breast Cancer Recurrence and Survival.

Authors: Sparano JA Crager M Gray RJ et al.

Source: NEJM evidence [NEJM Evid] 2024 Aug; Vol. 3 (8), pp. EVIDoa2300267. Date of Electronic Publication: 2024 Jul 23.

Publication Type: Journal Article; Meta-Analysis

Journal Info: Publisher: NEJM Group, a division of the Massachusetts Medical Society Country of Publication: United States NLM ID: 9918317485806676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2766-5526 (Electronic) Linking ISSN: 27665526 NLM ISO Abbreviation: NEJM Evid Subsets: MEDLINE

Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer.

Authors: Wescott EC Sun X Gonzalez-Ericsson P et al.

Source: Cancer research communications [Cancer Res Commun] 2024 Apr 24; Vol. 4 (4), pp. 1120-1134.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE

Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b study.

Authors: Layman RM Han HS Rugo HS et al.

Source: The Lancet. Oncology [Lancet Oncol] 2024 Apr; Vol. 25 (4), pp. 474-487.

Publication Type: Multicenter Study; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer.

Authors: Taylor BC Sun X Gonzalez-Ericsson PI et al.

Source: Cancer discovery [Cancer Discov] 2024 Feb 08; Vol. 14 (2), pp. 290-307.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical Trial.

Authors: Lehmann BD Abramson VG Dees EC et al.

Source: JAMA oncology [JAMA Oncol] 2024 Feb 01; Vol. 10 (2), pp. 193-201.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE